Viking Global Investors — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.
BiotechChapel Hill, US
Robin Walker(Executive Officer)Christopher Courts(Executive Officer)Jorge Bartolome(Executive Officer, Director)
BoardBenjamin Gomez(Director)Adam Koppel(Director)inMichael E. Bozik(Director)
Co-investorsARCH Venture PartnersBain Capital Life SciencesGV (Google Ventures)Access BiotechnologyMaverick CapitalSaturn Partners
Raleigh, US
Tomasz Dabrowski(Executive Officer, Director)Bartosz Jozefiak(Executive Officer)
BoardRohan Nirody(Director)Grzegorz Dzik(Director)Kazimierz Herba(Director)
AdmitHub provides AI-powered success coaching and conversation tools for higher education institutions to improve student engagement, retention, and outcomes.
AI & Machine LearningEdTechHR TechArlington, US
Andrew Magliozzi(Founder)in
Co-investorsFundersClubMichelson 20MM FoundationNXT VenturesTechstarsAlly Bridge GroupFountain Healthcare Partners+3 more
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)Jason Hannonin
BoardManus Rogan(Director)Antoine Papiernik(Director)
Co-investorsFountain Healthcare PartnersSofinnova PartnersAlly Bridge GroupGilde Healthcare
Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.
BiotechDigital HealthHealthtech
Vishal Patelin
Co-investorsAtlas VentureBorealis VenturesBorealis VenturesMagnetic VenturesOrbiMedAscenta Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.